CD19 and neoplasm: Notably, CD19 CAR-T cells primarily exhibited the CD45RA + /CCR7 + phenotype characteristic of stem cell memory T cells (67.5 ± 4.9%), which are known for their potent and durable anti-tumor efficacy (Fig. 1b).